GRFS · Grifols SA · Investor Relations
$8.15
-0.05 (-0.61%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$5.55B
Shares
680.58M
Volume · Nov 20
848.3K
Avg daily vol (3M)
622.34K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-02 | Q3 2026 Financial Results | Results publication |
| 2026-11-02 | Grifols Investor Relations – Q3 2026 Earnings Call Transcript | Earnings call |
| 2026-07-28 | H1 2026 Financial Results | Results publication |
| 2026-07-28 | Earnings conference call (announced in 6-K) | Earnings call |
| 2026-06-18 | Annual General Shareholders’ Meeting 2026 | Shareholder meeting |
| 2026-05-07 | Q1 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
| 2026-05-07 | Q1 2026 Financial Results | Results publication |
| 2026-02-26 | Full-Year 2025 Financial Results | Results publication |
| 2026-02-26 | Earnings conference call (announced in 6-K) | Earnings call |
| 2025-11-04 | Q3 2025 Financial Results | Results publication |
| 2025-11-04 | Grifols Q3 Earnings Call | Earnings call |
| 2025-07-29 | H1 2025 Financial Results | Results publication |
| 2025-07-29 | Grifols Investor Relations – Q2 2025 Earnings Call Transcript | Earnings call |
| 2025-06-19 | BIO International Convention | Event |
| 2025-06-05 | Annual General Shareholders’ Meeting | Shareholder meeting |
| 2025-06-04 | ISBT Congress | Event |
| 2025-05-21 | International Plasma Protein Congress (IPPC) 2025 | Event |
| 2025-05-12 | Q1 2025 Financial Results | Results publication |
| 2025-05-12 | Grifols Investor Relations – Q1 2025 Earnings Call Transcript | Earnings call |
| 2025-04-24 | World Orphan Drug Congress | Event |
| 2025-04-11 | Pharma 2025 (Reuters Events) | Event |
| 2025-02-27 | Capital Markets Day | Presentation |
| 2025-02-26 | Full Year 2024 Financial Results | Results publication |
| 2025-01-16 | J.P. Morgan Healthcare Conference | Conference |
| 2010-06-07 | Analyst and investors' presentation regarding acquisition of Talecris Biotherapeutics Holdings Corp | Presentation |
Key facts
CIK
1438569
CUSIP
398438408
13F (30d)
181 filings
153 filers
Visit website
Investor relations